Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Follicopeptide is a patented synthetic peptide, specifically designed to enhance hair growth. It is based on a modified segment of the endogenous human structural protein osteopontin, which is expressed in various tissues including hair follicles and bone. The mechanism of action involves agonism of the neuropilin-1 receptor (NRP-1), leading to revitalization of blood vessels in the scalp and stimulation of hair growth. Clinical studies have shown high safety and efficacy, with up to 70% response rates in individuals with androgenetic alopecia. The product is formulated as a stable topical gel for once-daily application and targets both men and women experiencing hair loss[1][5][6][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Follicopeptide.